1

Dottikon Es

Dottikon Es
Leadership team

Dr. Markus Blocher Dipl. Chem., Dr. sc. nat., Ph.D. (Chairman, CEO & MD)

Ms. Marlene Born Eidg. Dipl. (Chief Financial Officer)

Dr. Urs Brändli (Head of Processes & Technologies)

Products/ Services
Manufacturing, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Dottikon, Aargau, Switzerland
Established
1913
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
SWX:DESN
Overview
Location
Summary
Dottikon Es Holding AG engages in the manufacture and sale of performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. The company's chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also provides Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries. In addition, the company is involved in recycling, thermal recovery, and high-temperature incineration of waste streams, as well as wastewater treatment and purification activities; and provision of consulting services for investment companies, and software and engineering services. Dottikon Es Holding AG was founded in 1913 and is headquartered in Dottikon, Switzerland. Dottikon Es Holding AG is a subsidiary of EVOLMA Holding AG.
History

Dottikon ES was founded in 1952 near Zurich, Switzerland and has since then established itself as a key supplier of specialty active ingredients, organic and inorganic intermediates, and proprietary manufactured products in the pharma, agrochemical, and intellectual property protection markets

Mission
The mission of Dottikon ES is to provide active ingredients and intermediates that are of the highest quality and safety, manufactured with respect for the environment and people, and enabling customer value and innovation through expertise and service.
Vision
Dottikon ES’s vision is to be the global leader in specialty chemicals through customer focus, innovation and technology.
Key Team

Mr. Kurt Tripolt (Head of Recruiting & Admin.)

Ms. Karin Krause (Head of HR)

Dr. Thomas Rosatzin Ph.D. (Head of Purchasing)

Dr. Knut Hildebrandt Dipl. Chem., Dr. rer. nat. (Head of Quality Management)

Dr. Stephan Kirschbaum Dipl. Chem., Dr. rer. nat. (Head of Bus. Devel.)

Dr. Robert Dahinden (Head of Production)

Recognition and Awards
Dottikon ES has received numerous awards from its customers in the pharmaceutical, agrochemical and intellectual property protection industries for quality, service and innovation.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Dottikon Es
Leadership team

Dr. Markus Blocher Dipl. Chem., Dr. sc. nat., Ph.D. (Chairman, CEO & MD)

Ms. Marlene Born Eidg. Dipl. (Chief Financial Officer)

Dr. Urs Brändli (Head of Processes & Technologies)

Products/ Services
Manufacturing, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Dottikon, Aargau, Switzerland
Established
1913
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
SWX:DESN